Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Randomized Phase II Trial to Outline the Efficacy of Gemcitabine Containing Regimens (Gemcitabine/Carboplatin and Gemcitabine/Paclitaxel) When Used as Preoperative Chemotherapy In Patients With Stage I and II NSCLC

To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.

Inclusion Criteria:

• Histologically or cytologically confirmed non small cell lung cancer
• No prior chemotherapy or radiation for non small cell lung cancer
• No prior malignancy

Exclusion Criteria:

• Pregnancy or breastfeeding
• Serious concomitant disorders